University of Illinois at Urbana-Champaign researchers have developed a CRISPR-based diagnostic tool capable of detecting ...
Pancreatic cancer has a low survival rate and is usually found too late — this new test may help change that Researchers have developed an inexpensive blood test that they say can detect pancreatic ...
A novel, rapid blood test demonstrated potential for detecting early-stage pancreatic cancer, according to results of a ...
Enhanced assay granted approval by New York State’s Clinical Lab Evaluation Program (CLEP) for patients with DLBCL clonoSEQ is the only DLBCL MRD ...
A new study from researchers at the Oregon Health and Science University (OHSU) proposes a test called PAC-MANN, which could ...
A real-world study showed HER2DX guided treatment changes in approximately 48% of HER2-positive breast cancer cases.
A new assay rapidly detected pancreatic ductal adenocarcinoma and differentiated it from noncancer pancreatic diseases by measuring cancer-associated protease activity in a small amount of blood.
Researchers indicate that the Lumipulse p-tau217 assay may reduce over 50% of lumbar punctures performed for diagnosing Alzheimer's disease.
He noted that other assays studied in pancreatic cancer have only examined a handful of samples. "When they publish a second paper, it usually shows that [the test] fails for early detection," he ...
Tulane University researchers have developed a CRISPR-based test that diagnoses Pneumocystis jirovecii pneumonia (PJP) - a ...
REVEAL GENOMICS®, a pioneering Barcelona-based biotech company dedicated to advancing precision oncology, is proud to announce the publication of a groundbreaking study demonstrating the clinical ...
Patients with irritable bowel syndrome are more likely to benefit from a diet that eliminates any food triggering an IgG ...